International Research in Infectious Diseases, including AIDS (R01) | PAR 17 142

Opportunity Information: Apply for PAR 17 142

The National Institutes of Health (NIH) funding opportunity titled "International Research in Infectious Diseases, including AIDS (R01)" (Funding Opportunity Number: PAR-17-142) is a discretionary grant program that uses the NIH R01 research project grant mechanism to support investigator-driven research on infectious diseases, explicitly including HIV/AIDS. The central purpose is to encourage research projects that address infectious disease questions that are directly relevant to, and of clear importance to, the applicant's own country. In practice, this means the program is designed to fund studies that respond to local disease burdens, transmission patterns, health system realities, and country-specific scientific priorities, rather than projects primarily driven by U.S.-based institutional components or U.S.-centered needs.

A defining feature of this FOA is its eligibility framework, which is narrowly focused on independent, non-U.S. applicants. Eligible applicants are organizations and institutions located in eligible foreign countries, described in the announcement as non-domestic (non-U.S.) entities, including both foreign organizations and foreign institutions. At the same time, the FOA draws a firm boundary around what is not allowed: non-domestic components of U.S. organizations are not eligible to apply, and "foreign components" (as that term is defined in the NIH Grants Policy Statement) are not allowed under this announcement. Put plainly, the intent is for the applicant and the work to be anchored in the eligible foreign institution itself, rather than structured as an overseas extension of a U.S. organization or as a foreign component attached to a U.S. prime applicant. The FOA also notes that applicants should consult the full opportunity text for the detailed eligibility rules, reflecting that country eligibility and institutional status can be determinative.

From a topical standpoint, the opportunity supports research related to infectious diseases broadly, with explicit inclusion of AIDS/HIV, under NIH's health research mission. Because it is an R01 mechanism, the program is typically suited to well-developed research ideas with clearly articulated aims, a strong scientific premise, and a feasible plan for execution, analysis, and dissemination. While the summary text provided does not list specific scientific topics, the scope implied by "infectious diseases, including AIDS" generally encompasses areas such as disease epidemiology, pathogenesis, transmission dynamics, prevention and behavioral interventions, diagnostics, therapeutics, implementation research, health services research related to infectious disease control, and other studies that can generate generalizable knowledge relevant to the applicant country. The core emphasis is that the research should align with infectious disease priorities and needs in the foreign country where the eligible institution is based.

Administratively, the opportunity is issued by the National Institutes of Health and is categorized as a grant under the "Health" funding activity category. The associated CFDA numbers listed are 93.855 and 93.856, which correspond to NIH program areas related to infectious diseases and HIV/AIDS research. The opportunity was created on 2017-01-27, and the original closing date listed is 2019-08-22, indicating the FOA was active during that period. The provided source data does not specify an award ceiling or the expected number of awards (those fields are blank), so the summary cannot reliably state maximum funding levels or anticipated award counts based solely on the information given.

Overall, this FOA is best understood as a pathway for eligible, non-U.S. research institutions to obtain NIH R01 support for rigorous, locally relevant infectious disease research, while explicitly preventing applications that are essentially foreign outposts of U.S. organizations or that rely on NIH-defined foreign component arrangements. Applicants would need to rely on the full FOA text for the definitive eligibility criteria and application requirements, but the high-level intent is clear: strengthen and support investigator-initiated infectious disease research led by qualified institutions in eligible foreign countries, focusing on diseases and public health challenges that matter most in their own settings.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "International Research in Infectious Diseases, including AIDS (R01)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855, 93.856.
• This funding opportunity was created on 2017-01-27.
• Applicants must submit their applications by 2019-08-22. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Others.

Apply for PAR 17 142

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: